Dr (Col.) R Ranga Rao

About Doctor

Dr (Col.) R Ranga Rao is a well-experienced Medical Oncologist.
He has more than 30 years of experience in the field of Medical Oncology.
He holds expertise in managing and treating cancers related to the Lung, Pleura, Breast, Ovarian, Cervical, Esophagus, Stomach, Small Intestine, Colon, Rectum, Liver, Gall Bladder, Pancreas, Bone, Skin, Lymphomas of all types, Brain Tumors, Kidney, Urinary Bladder, Prostrate, Head and Neck.
He has been honored with several awards and recognitions.
His special interests are Chemotherapy, Targeted Therapy, Hormonal Therapy, Supportive & Palliative Care, and Precision Care.
He is an active member of various organizations including the American Society of Clinical Oncology ( ASCO), European Society of Medical Oncology (ESMO), and Indian Society of Medical and Pediatric Oncology (ISMPO).
Prior to working with Paras Hospitals, he has worked with prestigious healthcare institutions across India.

30 Years Experience

Medical Oncology Chemotherapy Targeted Therapy Hormonal Therapy Supportive and Palliative Care Immunotherapy Precision Care

Awarded ‘Vishisht Seva Medal’ by President of India for meritorious and distinguished service rendered in Armed Forces on the eve of Republic Day 2006. - Col KK Gupta Memorial Gold Medal 1984 for standing first in the Advance course Medicine 1982-84. - Lt Gen R S Hoon Award 1994 for the original paper entitled “Immuno-phenotyping of Acute Leukaemia” - Best Original Article Award MJAFI 1995 for the original paper entitled “use of Long –term venous Access in patients of Acute Leukaemia and NHL”. - Lt Gen RS Hoon Award 1996, for the original paper entitled “Preliminary analysis of Alpha Interferon Therapy in Chronic Myeloid Leukaemia”. - Air Marshall Ajit Nath Guru Shanti Devi Award 1997 for the original paper entitled “Impact of prophylactic use of Colony Stimulating Factors on neutropenia and infections in moderately intensive chemotherapy”. 2nd Best Poster Award Merck Serrano Oncology Summit Hong Kong March, 2012 : Palliative weekly chemotherapy along with cetuximab in recurrent and metastatic head and neck cancers an observational phase IV Retrospective Analysis.